Conditions: Psoriasis
Keywords: Psoriasis
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 181
Healthy volunteers: no

Brief summary:
This study is an open-label extension of study 20090062 to evaluate extended subcutaneous dosing.

Detailed description:
This study is an open-label extension of study 20090062 to evaluate extended subcutaneous dosing of AMG 827 for up to 362 weeks.

Arms:
arm 1: AMG 827

Interventions: intervention 1: AMG 827
Intervention descriptions: intervention 1: 210 mg SC or 140 mg SC

Protocol document: